Wealth Awesome
TSX closed
Loading markets…
PARTNER SPOTLIGHT
CIBC Investor's Edge

Buy the stocks you believe in, for less

For a limited time, trade fractional shares commission-free.¹

  • ✓Own a piece of your favourite companies without buying an entire share
  • ✓Stocks and ETFs, from as little as $1
  • ✓In any account: TFSA, FHSA, RRSP and more

¹Online fractional trades in North American equities under one share, Sep 15, 2026 to Oct 31, 2027. One qualifying order per security, per side, per day. Conditions apply.

Insider · SEDI

Rene Goehrum

Rene Goehrum has reported about $40.0M in shares of Biosyent Inc. on SEDI, Canada's insider filing system. That is #216 among the insiders we track.

Holdings as of November 17, 2026 · 10% holder

Disclosed holdings

$40.0M

Companies

1

Buys / sells (12 months)

0 / 1

Net bought (12 months)

−$77K

About these filings

Directors, officers and large shareholders of Canadian-listed companies must report their trades on SEDI, usually within five days. A filing shows what they did with their own shares, not why: people buy and sell for many reasons, including taxes, diversification and option exercises. The data here is a record of those filings and what the stocks did afterwards, not a recommendation.

Follow Rene Goehrum

Get an email when they file a new trade on SEDI. Free, with the Wealth Awesome newsletter.

Holdings by company

Latest balance reported on SEDI for each company (direct and through holding companies), valued at the latest close.

CompanyRoleSharesValueLast filing
Biosyent Inc.RX.V · all insiders10% holderincl. indirect2,244,982$40.0M2026-06-23

Track record after buying

Every open-market buy since 2016, and what the stock did 3, 6 and 12 months later (adjusted closes; same-day buys of one stock count once; each return capped at +300%).

Buys

1

Avg after 3 months

+0.0%

Avg after 6 months

+0.0%

Avg after 12 months

+0.0%

Up after 1 year

0% of 1

DateCompanyBought3 mo6 mo12 mo
2020-03-31Biosyent Inc.RX.V$14K+0.0%+0.0%+0.0%

Recent insider filings

DateCompanyTypeSharesPriceBalance after
2026-06-23Biosyent Inc.Common Shares - OptionsExercise of options-8,557$6.2033,301
2026-06-23Biosyent Inc.Common SharesSell-5,525$13.90657,221
2026-06-23Biosyent Inc.Common SharesExercise of options8,557$6.20662,746
2026-03-31Biosyent Inc.Rights (Common Shares)Exercise of rights-20,201—48,636
2026-03-31Biosyent Inc.Common SharesExercise of rights10,100$14.42654,189
2026-03-25Biosyent Inc.Rights (Common Shares)Grant of rights6,333—68,837
2026-03-24Biosyent Inc.Rights (Common Shares)Grant of rights10,884—62,504
2026-03-24Biosyent Inc.Rights (Common Shares)Grant of rights10,844——
2026-03-01Biosyent Inc.Rights (Common Shares)Grant of rights6,333——
2025-12-31Biosyent Inc.Rights (Common Shares)Acquisition or disposition…1,010$11.7651,620
2025-12-31Biosyent Inc.Rights (Common Shares)Acquisition or disposition…877$11.76—
2025-12-31Biosyent Inc.Common SharesAcquisition or disposition…2,459$11.61644,089
2025-03-31Biosyent Inc.Rights (Common Shares)Exercise of rights-15,940—50,610
2025-03-31Biosyent Inc.Common Shares - OptionsExpiration of options-4,512$10.9741,858
2025-03-31Biosyent Inc.Common SharesExercise of rights7,970$11.15641,630
2025-03-31Biosyent Inc.Common SharesExercise of rights-7,970$11.15—
2025-03-31Biosyent Inc.Common SharesExercise of rights7,970$11.15—
2025-03-18Biosyent Inc.Rights (Common Shares)Grant of rights13,582—66,550
2024-12-31Biosyent Inc.Rights (Common Shares)Acquisition or disposition…951—52,968
2024-12-31Biosyent Inc.Common SharesAcquisition or disposition…2,130$9.83633,660
2024-06-13Biosyent Inc.Common SharesExercise of options1,522$7.45631,530
2024-06-12Biosyent Inc.Common Shares - OptionsExercise of options-1,522$7.4546,370
2024-06-12Biosyent Inc.Common Shares - OptionsExercise of options1,522$7.45—
2024-06-12Biosyent Inc.Common SharesSell-1,522$9.38630,008
2024-03-27Biosyent Inc.Rights (Common Shares)Grant of rights17,103—52,017
2024-03-19Biosyent Inc.Rights (Common Shares)Exercise of rights-18,661—34,914
2024-03-19Biosyent Inc.Common SharesExercise of rights9,330$8.50631,530
2023-12-31Biosyent Inc.Rights (Common Shares)Acquisition or disposition…1,164—53,575
2023-12-31Biosyent Inc.Common SharesAcquisition or disposition…2,625$7.75622,200
2023-03-31Biosyent Inc.Rights (Common Shares)Exercise of rights-31,510—52,411
2023-03-31Biosyent Inc.Rights (Common Shares)Grant of rights19,147—83,921
2023-03-31Biosyent Inc.Common SharesExercise of rights15,931—619,575
2023-03-31Biosyent Inc.Common SharesExercise of rights-31,862——
2022-12-31Biosyent Inc.Common SharesAcquisition or disposition…2,074$8.08603,644
2022-03-31Biosyent Inc.Rights (Common Shares)Grant of rights15,182—64,774
2021-12-31Biosyent Inc.Common SharesAcquisition or disposition…1,516$7.71601,570
2021-03-19Biosyent Inc.Rights (Common Shares)Grant of rights18,082—49,592
2020-12-31Biosyent Inc.Common SharesAcquisition or disposition…1,063$5.04600,054
2020-03-31Biosyent Inc.Rights (Common Shares)Grant of rights31,510—31,510
2020-03-31Biosyent Inc.Common SharesBuy4,000$3.60598,991

Free with a Wealth Awesome account

Keep analysing Rene Goehrum, free

  • Every WA Score, ranking and table
  • Insider track records and SEDI filings
  • Earnings history and analyst targets for every stock

Email only, no password, no card. Already a member? Use the same button to sign in.

How we count it: for each company we take the latest share balance Rene Goehrum reported on SEDI for common-type shares (held directly or through holding companies) and value it at the latest close. Options, warrants and share units are left out, and so are balances with no filing in the last three years (insiders stop reporting when they leave the role). This is not a net worth figure: it covers only Canadian-listed shares reported on SEDI, and balances can lag until the next filing.

Canada's biggest insider shareholders · Latest insider trades

Awesome Portfolio™

Our 10 best Canadian stocks, in one list.

14.8% a year since 2017 against 9.7% for the S&P/TSX Composite (+5.0 points a year). Reviewed every month.

See the portfolio →